Medical weight management | New York
Call before traveling and name the exact service and location. Confirm the appointment, provider, records, tests, and medicine arrangements. A general walk-in visit does not guarantee a prescription, administration, specialist treatment, or a dietitian appointment that day.
Wegovy injection contains semaglutide and is taken once weekly. Its approved uses include weight management, cardiovascular risk reduction in qualifying adults, and treatment of qualifying noncirrhotic MASH. The injection, higher-dose presentation, and tablet have different indication and dose details.
For weight management, Wegovy injection is approved for adults with obesity, selected adults with overweight and a weight-related condition, and children 12 years and older with obesity. Cardiovascular and MASH indications apply to specified adults. Pediatric treatment needs age-appropriate care.
Review the indication, risks, previous medicines, and ability to continue treatment. Start and increase the exact formulation under the prescriber’s plan. Learn injection use and storage for the device dispensed. Add nutrition support and agree on follow-up, side-effect reporting, and refills.
Bring your weight and treatment history, medicines and supplements, relevant glucose, kidney, and lipid results, and the exact product you have used before. Mention previous side effects, eye disease, eating difficulties, and pregnancy plans. If insurance denied treatment, bring the denial and plan details.
Review a personal or family history of medullary thyroid cancer, MEN 2, severe stomach-emptying problems, pancreatitis, gallbladder disease, allergies, and pregnancy plans before treatment. Nausea, vomiting, constipation, or diarrhea can occur. Persistent severe abdominal pain or inability to keep fluids down needs emergency department assessment now. Call 911 for breathing difficulty, a severe allergic reaction, loss of consciousness or unsafe travel. Tell the anesthesia team about treatment before a procedure. Do not combine GLP-1 medicines or change the dose yourself. For weight or cardiovascular risk treatment, discontinue when pregnancy is recognized and plan at least a two-month interval before pregnancy. The MASH label has separate benefit-risk language that needs specialist review.
Review weight trend, appetite, food and fluid intake, bowel symptoms, and treatment tolerability. Check glucose and adjust other diabetes medicines with the prescriber when relevant. Agree on how to contact the team between visits and what to do if a refill is delayed. Continued treatment depends on benefit, safety, access, and your goals.
Confirm the exact service, clinician, formulation, appointment, and refill route before booking. The evaluation, tests, medicine, administration, and follow-up may have separate costs and benefits. Ask for current estimates and required records. An FDA-approved drug or a clinic address does not establish pharmacy stock, onsite treatment, coverage, or a prescription. If access changes, contact the treating team before interrupting treatment.
The visit, laboratory tests, and medicine can have different coverage rules. Ask the plan about the exact brand and indication, exclusions, prior authorization, required records, deductible, copay, and dispensing route. Bring a denial for review of its specific reason. Nao Medical or the prescriber cannot guarantee approval. Confirm current participation and costs before booking.
Do not combine or overlap GLP-1 medicines or brands yourself. Product labels do not recommend this combination. The prescriber should review the exact current treatment and write any switch plan.
FDA approval, manufacturer supply, a pharmacy’s ability to fill the exact strength, and Nao Medical service availability are different questions. Confirm the exact product and refill route before a treatment change. Local supply can vary. Call before traveling, and do not interrupt prescribed treatment based on a website listing.
The Wegovy injection has a US chronic-weight-management indication for qualifying adolescents age 12 and older with obesity. Wegovy tablets have adult indications, so the same age rule cannot be applied to every formulation. A pediatric assessment reviews growth, health, family support and product-specific safety; a clinic listing does not establish pediatric prescribing availability.
Yes. Before starting, confirm that the prescribed strength can be filled and that refills are practical and affordable. An interruption can affect escalation or restarting, so tell the prescriber about a delay before the next dose. Commercial availability does not mean every local pharmacy has the required presentation when needed.
The clinician should identify the exact indication, age, weight and cardiovascular history, liver diagnosis when relevant, and current medicines. The review also covers diabetes and eye history, gastrointestinal or gallbladder concerns, kidney context, pregnancy and procedure plans, contraindications, and device readiness.
The injection starts at 0.25 mg once weekly and uses staged escalation. Adult weight maintenance is usually 1.7 mg or 2.4 mg weekly. The current label allows 7.2 mg weekly for certain adults after at least four weeks at 2.4 mg when additional weight reduction is clinically indicated. Other indications have specific maintenance instructions.
Follow-up should address response, gastrointestinal effects, hydration and kidney concerns, gallbladder or pancreatitis symptoms, blood glucose when relevant, retinopathy history, heart rate, hypersensitivity, and injection technique. MASH care requires liver-specific monitoring and coordination.
The clinician should identify the exact indication, age, weight and cardiovascular history, liver diagnosis when relevant, and current medicines. The review also covers diabetes and eye history, gastrointestinal or gallbladder concerns, kidney context, pregnancy and procedure plans, contraindications, and device readiness.
Follow-up should address response, gastrointestinal effects, hydration and kidney concerns, gallbladder or pancreatitis symptoms, blood glucose when relevant, retinopathy history, heart rate, hypersensitivity, and injection technique. MASH care requires liver-specific monitoring and coordination.
Before starting or changing Wegovy, your clinician reviews the exact formulation and dose, age eligibility, injection technique, costs, safety concerns and follow-up. Liver-disease treatment may also require specialist coordination.
An evaluation may lead to another medicine, more testing, a referral, or no medication change.
The health plan and dispensing pharmacy make coverage and fulfillment decisions. Prior authorization may be required.
The clinic cards below show places to start an evaluation. They do not prove that a product is stocked, dispensed, taught, or administered at that site.
Bronx
932 E 174th St, Bronx, NY 10460
Choose a nearby clinic for an evaluation and care coordination. Before traveling, confirm the appointment type and any testing, medication teaching or treatment you need.
Queens
37-15 23rd Ave, Astoria, NY 11105
Choose a nearby clinic for an evaluation and care coordination. Before traveling, confirm the appointment type and any testing, medication teaching or treatment you need.
Bronx
2063A Bartow Ave, Bronx, NY 10475
Choose a nearby clinic for an evaluation and care coordination. Before traveling, confirm the appointment type and any testing, medication teaching or treatment you need.
Brooklyn
341 Eastern Pkwy, Brooklyn, NY 11216
Choose a nearby clinic for an evaluation and care coordination. Before traveling, confirm the appointment type and any testing, medication teaching or treatment you need.
Long Island
232 W Old Country Rd, Hicksville, NY 11801
Choose a nearby clinic for an evaluation and care coordination. Before traveling, confirm the appointment type and any testing, medication teaching or treatment you need.
Queens
80-10 Northern Blvd, Jackson Heights, NY 11372
Choose a nearby clinic for an evaluation and care coordination. Before traveling, confirm the appointment type and any testing, medication teaching or treatment you need.
Queens
90-18 Sutphin Blvd, Jamaica, NY 11435
Choose a nearby clinic for an evaluation and care coordination. Before traveling, confirm the appointment type and any testing, medication teaching or treatment you need.
Queens
30-07 36th Ave, Astoria, NY 11106
Choose a nearby clinic for an evaluation and care coordination. Before traveling, confirm the appointment type and any testing, medication teaching or treatment you need.
Long Island
135 Mineola Blvd, Mineola, NY 11501
Choose a nearby clinic for an evaluation and care coordination. Before traveling, confirm the appointment type and any testing, medication teaching or treatment you need.
Manhattan
259 1st Ave, New York, NY 10003
Choose a nearby clinic for an evaluation and care coordination. Before traveling, confirm the appointment type and any testing, medication teaching or treatment you need.
Brooklyn
308 Graham Ave, Brooklyn, NY 11211
Choose a nearby clinic for an evaluation and care coordination. Before traveling, confirm the appointment type and any testing, medication teaching or treatment you need.
Explore Nao Medical's broader weight-management program and treatment options.
Review the adult tablet pathway and its fasting administration rules.
Review Wegovy's liver indication, diagnosis, and specialist-coordination questions.
Compare tirzepatide using its own label and safety information.
Review a different oral GLP-1 product and interaction profile.
Content was updated August 2, 2026 from the sources cited here. Medical guidance, prescribing information, medication availability, and insurance rules can change. A licensed clinician must confirm current information and determine each patient's eligibility, testing, treatment, administration setting, and follow-up. Call 911 for a medical emergency. Contact Nao Medical with a question or correction.
(917) 310-3371